Forkhead Transcription Factor FOXO1 Inhibits Angiogenesis in Gastric Cancer in Relation to SIRT1
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose We previously reported that forkhead transcription factors of the O class 1 (FOXO1) expres- sion in gastric cancer (GC) was associated with angiogenesis-related molecules. However, there is little experimental evidence for the direct role of FOXO1 in GC. In the present study, we investigated the effect of FOXO1 on the tumorigenesis and angiogenesis in GC and its relationship with SIRT1. Materials and Methods Stable GC cell lines (SNU-638 and SNU-601) infected with a lentivirus containing FOXO1 shRNA were established for animal studies as well as cell culture experiments. We used xenograft tumors in nude mice to evaluate the effect of FOXO1 silencing on tumor growth and angiogenesis. In addition, we examined the association between FOXO1 and SIRT1 by immunohistochemical tissue array analysis of 471 human GC specimens and Western blot analysis of xenografted tumor tissues. Results In cell culture, FOXO1 silencing enhanced hypoxia inducible factor-1α (HIF-1α) expression and GC cell growth under hypoxic conditions, but not under normoxic conditions. The xenograft study showed that FOXO1 downregulation enhanced tumor growth, microvessel areas, HIF-1α activation and vascular endothelial growth factor (VEGF) expression. In addi- tion, inactivated FOXO1 expression was associated with SIRT1 expression in human GC tissues and xenograft tumor tissues. Conclusion Our results indicate that FOXO1 inhibits GC growth and angiogenesis under hypoxic condi- tions via inactivation of the HIF-1α–VEGF pathway, possibly in association with SIRT1. Thus, development of treatment modalities aiming at this pathway might be useful for treating GC.
Abstract
Purpose We previously reported that forkhead transcription factors of the O class 1 (FOXO1) expres- sion in gastric cancer (GC) was associated with angiogenesis-related molecules. However, there is little experimental evidence for the direct role of FOXO1 in GC. In the present study, we investigated the effect of FOXO1 on the tumorigenesis and angiogenesis in GC and its relationship with SIRT1. Materials and Methods Stable GC cell lines (SNU-638 and SNU-601) infected with a lentivirus containing FOXO1 shRNA were established for animal studies as well as cell culture experiments. We used xenograft tumors in nude mice to evaluate the effect of FOXO1 silencing on tumor growth and angiogenesis. In addition, we examined the association between FOXO1 and SIRT1 by immunohistochemical tissue array analysis of 471 human GC specimens and Western blot analysis of xenografted tumor tissues. Results In cell culture, FOXO1 silencing enhanced hypoxia inducible factor-1α (HIF-1α) expression and GC cell growth under hypoxic conditions, but not under normoxic conditions. The xenograft study showed that FOXO1 downregulation enhanced tumor growth, microvessel areas, HIF-1α activation and vascular endothelial growth factor (VEGF) expression. In addi- tion, inactivated FOXO1 expression was associated with SIRT1 expression in human GC tissues and xenograft tumor tissues. Conclusion Our results indicate that FOXO1 inhibits GC growth and angiogenesis under hypoxic condi- tions via inactivation of the HIF-1α–VEGF pathway, possibly in association with SIRT1. Thus, development of treatment modalities aiming at this pathway might be useful for treating GC.
참고문헌 (24)
- Zhang Y, "FoxO family members in cancer", Cancer Biol Ther, 12, pp.253~259 (2011)
- Kim SY, "Constitutive phosphorylation of the FOXO1 transcription factor in gastric cancer cells correlates with microvessel area and the expressions of angiogenesis-related molecules", BMC Cancer, 11, pp.264~ (2011)
- Srivastava RK, "FOXO transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol", Mol Cell Biochem, 337, pp.201~212 (2010)
- Song NY, "Janus-faced role of SIRT1 in tumorigenesis", Ann N Y Acad Sci, 1271, pp.10~19 (2012)
- Maiese K, "Translating cell survival and cell longevity into treatment strategies with SIRT1", Rom J Morphol Embryol, 52, pp.1173~1185 (2011)
- Lim JH, "Sirtuin 1modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha", Mol Cell, 38, pp.864~878 (2010)
- Yamamoto H, "An updated review of gastric cancer in the next-generation sequencing era : insights from bench to bedside and vice versa", World J Gastroenterol, 20, pp.3927~3937 (2014)
- 이준행, "Clinical Practice Guidelines for Gastric Cancer in Korea: An Evidence-Based Approach", Journal of Gastric Cancer, 14(2), pp.87~104 (2014), 대한위암학회[DOI]
- Giannakou ME, "The interaction between FOXO and SIRT1 : tipping the balance towards survival", Trends Cell Biol, 14, pp.408~412 (2004)
- Nam SY, "A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-kappaB promotes gastric tumour growth and angiogenesis", Br J Cancer, 104, pp.166~174 (2011)
- Tang ED, "Negative regulation of the forkhead transcription factor FKHR by Akt", J Biol Chem, 274, pp.16741~16746 (1999)
- Kim WH, "Apoptosis in human fibrosarcoma cells is induced by a multimeric synthetic Tyr-Ile-Gly-Ser-Arg(YIGSR)-containing polypeptide from laminin", Cancer Res, 54, pp.5005~5010 (1994)
- Lee HS, "Tumour suppressor gene expression correlates with gastric cancer prognosis", J Pathol, 200, pp.39~46 (2003)
- 홍순선, "HIF-1alpha: a Valid Therapeutic Target for Tumor Therapy", Cancer Research and Treatment, 36(6), pp.343~353 (2004), 대한암학회
- Stoeltzing O, "Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation", J Natl Cancer Inst, 96, pp.946~956 (2004)
- Wang Y, "HIF-1alpha and HIF-2alpha correlate with migration and invasion in gastric cancer", Cancer Biol Ther, 10, pp.376~382 (2010)
- Feng AN, "Expression of SIRT1 in gastric cardiac cancer and its clinicopathologic significance", Int J Surg Pathol, 19, pp.743~750 (2011)
- Gong W, "Expression of autocrine motility factor correlates with the angiogenic phenotype of and poor prognosis for human gastric cancer", Clin Cancer Res, 11, pp.5778~5783 (2005)
- Furuyama T, "Abnormal angiogenesis in Foxo1(Fkhr)-deficient mice", J Biol Chem, 279, pp.34741~34749 (2004)
- Bakker WJ, "FOXO3a is activated in response to hypoxic stress and inhibits HIF1-induced apoptosis via regulation of CITED2", Mol Cell, 28, pp.941~953 (2007)
- Laemmle A, "Inhibition of SIRT1 impairs the accumulation and transcriptional activity of HIF-1alpha protein under hypoxic conditions", PLoS One, 7, pp.33433~ (2012)
- Sun P, "Lentivirus-mediated siRNA targeting VEGF inhibits gastric cancer growth in vivo", Oncol Rep, 28, pp.1687~1692 (2012)
- Hou J, "Early apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation", Curr Neurovasc Res, 7, pp.95~112 (2010)
- Maiese K, "A"FOXO"in sight : targeting Foxo proteins from conception to cancer", Med Res Rev, 29, pp.395~418 (2009)